Epitope-Based Specific Antibody Modification

23 March 2023, Version 1
This content is a preprint and has not undergone peer review at the time of posting.


Modified antibodies play essential roles in various fields, such as analysis, diagnosis, and therapy, which require modified antibodies with optimal physical and biological properties. To this aim, the development of methods for site-selective antibody modification is crucial. Herein, we introduce a Fab region–selective antibody modification method using epitope-based affinity labeling. Although affinity labeling exploiting the high affinity between an antibody and its epitope may sound straightforward, it remains as a challenge probably due to target affinity loss caused by modification around the epitope binding site. By thoroughly screening of the modifying agent structure, reaction conditions, and purification methods, we achieved to develop an efficient method for the selective modification of the Fab region of the antibody while maintaining its high affinity for the epitope.


Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.